# A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment

> **NCT00002334** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 3000 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Saquinavir
- **DRUG:** Zidovudine
- **DRUG:** Zalcitabine

## Key facts

- **NCT ID:** NCT00002334
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 3000 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002334, "A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*